NM_000512.5:c.1502G>C
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000512.5(GALNS):āc.1502G>Cā(p.Cys501Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000512.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1406492Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 694396
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-IV-A Pathogenic:2Uncertain:2
- -
The observed missense c.1502G>C(p.Cys501Ser) variant in GALNS gene has been reported previously in homozygous or compound heterozygous state in individual(s) affected with Mucopolysaccharidosis IV A (Bidchol et al., 2014). This variant is absent in gnomAD Exomes. This variant has been reported to the ClinVar database as Uncertain Significance / Likely Pathogenic. The amino acid Cys at position 501 is changed to a Ser changing protein sequence and it might alter its composition and physico-chemical properties. The amino acid change p.Cys501Ser in GALNS is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. Multiple lines of computational evidence (Polyphen - Damaging, SIFT - Damaging, and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. This mutation is present in protein structure disrupting hotspot region (Bidchol et al., 2014). For these reasons, this variant has been classified as Pathogenic. -
The variant has shown a homozygous status for c.1502G>C (p.Cys501Ser) in exon 14 of the GALNS gene. This variant is not reported in 1000 genomes and gnomAD databases. The in-silico prediction of the variant is disease causing by LRT, Mutation Taster, SIFT and PROVEAN. -
In vivo functional studies supportive of a damaging effect on the gene product (low to null enzymatic activity in homozygotes; PS3_supporting); absent from gnomAD v2.1.1 (PM2_moderate); multiple lines of computational evidence support a deleterious effect on the gene (PP3_supporting) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.